Who Paid My Doc
Marqibo
Drug Oncology
NDC 72893-008-03
General payments
$7,135
Research payments
$234,548
Through program year 2022, $7,135 in general payments and $234,548 in research payments were reported against Marqibo (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $1,128 | 71 |
| 2022 | Research | $84,458 | 5 |
| 2021 | General | $1,168 | 70 |
| 2021 | Research | $106,840 | 3 |
| 2020 | General | $2,156 | 145 |
| 2020 | Research | $43,250 | 3 |
| 2019 | General | $2,684 | 149 |
Breakdown
The top 5 of 70 recipients; each share is of general payments naming this product in 2022.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
435 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.